So Young Medical Apologizes to Ma Sichun, Initiates Internal Review and Accountability

Deep News06-12

On the evening of June 12th, So Young Medical issued a statement on social media, offering a formal apology to actress Ma Sichun, her family, her fans, and the general public regarding a recent article with a highly inappropriate title.

The company explained that on June 11th, its official WeChat public account published an article titled "Ma Sichun, Died at Age 37." The title was derived from a segment in a previous public interview where Ma Sichun discussed writing her own obituary as a life reflection exercise. However, the title was taken out of context and used severely inappropriate wording, creating ambiguity and causing serious offense to Ma Sichun and her family, as well as alarming and misleading her fans and the wider online community.

So Young expressed its sincere apologies to Ma Sichun, her family, and her fans, and to all those disturbed by the headline. The company acknowledged that the publication of such an improper title exposed flaws in its review process, with primary responsibility lying with management.

The company outlined the actions it has taken and will continue to implement. First, the offending article was immediately removed, and a review of all historical content across its platforms has been conducted. Second, a comprehensive upgrade of the multi-level review mechanism for titles and content is underway. Third, an internal review and accountability process has been initiated.

So Young stated that Ma Sichun's candid sharing of her reflections on life in that interview deserved to be treated with seriousness and respect, and the headline failed to do so, which is the core issue requiring reflection. The company reiterated its apology.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment